Oncology
First century CE — Pliny the Elder, Roman natural historian, noted respiratory illness among asbestos workers
Mesothelioma was a cancer that physicians struggled to identify and name for much of medical history, largely because its connection to asbestos exposure took decades to establish. Early clinicians frequently misattributed its symptoms to other pulmonary or abdominal conditions, and it was not recognized as a distinct pathological entity until the mid-twentieth century. The story of mesothelioma's historical understanding is inseparable from the industrial expansion that brought asbestos into widespread use.
Historical Narrative
The mineral asbestos had been known to ancient civilizations for thousands of years, prized for its seemingly magical resistance to fire. Ancient Greeks and Romans marveled at its properties, and some classical writers noted that workers who handled the fibrous material appeared to suffer unusual respiratory ailments, though no systematic connection was drawn. Pliny the Elder, writing in the first century CE, reportedly observed that slaves who worked with asbestos suffered from lung troubles, making his observations among the earliest recorded hints that the material posed biological dangers.
During the medieval period, asbestos continued to be regarded with fascination rather than suspicion. It appeared in the courts of kings and emperors as a curiosity, woven into fabrics that seemed to resist flame. No medical tradition of the era connected its handling to internal disease, and healers of the period lacked both the anatomical knowledge and the pathological frameworks necessary to identify what would later be called mesothelioma.
The industrial revolution fundamentally changed the scale of human asbestos exposure. As the nineteenth century progressed, asbestos was incorporated into shipbuilding, insulation, and construction materials on an enormous scale. Factory inspectors in Britain during the 1890s began filing reports documenting unusually high rates of early death and lung disease among asbestos textile workers. In 1898 and 1899, British factory inspector Lucy Deane formally documented the harmful pulmonary effects observed in asbestos workers, contributing to some of the earliest official acknowledgments that occupational exposure was dangerous.
By the early twentieth century, physicians began publishing case reports of unusual lung scarring in asbestos workers. In 1906, French physician Auribault published findings on mortality among asbestos mill workers that pointed toward occupational hazard. The term "asbestosis" was formally coined in 1927 by the British physician W.E. Cooke, who used it to describe the characteristic scarring of lung tissue he observed at autopsy in a former asbestos worker. This diagnostic milestone helped legitimize the field of occupational lung disease, though mesothelioma itself remained unnamed and poorly characterized.
The critical intellectual leap connecting mesothelioma specifically to asbestos came in 1960, when South African physician J.C. Wagner published a landmark study examining pleural tumors in individuals from the Northwestern Cape, a region with significant crocidolite asbestos mining activity. Wagner and his colleagues documented a striking geographic and occupational clustering of these pleural malignancies, providing the first robust epidemiological evidence that asbestos exposure and mesothelioma were causally linked. This publication is widely considered the founding document of modern mesothelioma research.
Following Wagner's work, researchers in the United States, Britain, and Australia began retrospective investigations into the health records of shipyard workers, insulation installers, and miners. Irving Selikoff at the Mount Sinai School of Medicine conducted extensive longitudinal research through the 1960s and 1970s, documenting mesothelioma rates among asbestos-exposed worker populations and helping to translate epidemiological findings into public health awareness. Selikoff became one of the most prominent figures in establishing the scientific and legal understanding of asbestos-related disease.
Throughout the latter half of the twentieth century, mesothelioma's history became entangled with industrial litigation as internal documents from asbestos manufacturers revealed that corporate leaders had possessed evidence of health risks decades before public disclosure. This dimension of its history made mesothelioma not only a medical story but also a defining episode in the history of occupational health regulation and corporate accountability.
Key Historical Figures
Historical narrative only — this page describes how Mesothelioma was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.